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http://dxObjective: Different cerebral protection strategies are currently being practiced during noncomplex hemiarch
surgery without randomized control studies to show their relative efficacy. We hypothesized that deep hypother-
mic circulatory arrest (DHCA) alone was adequate for cerebral protection in noncomplex hemiarch surgery.
Methods: Four hundred sixty-seven patients underwent noncomplex hemiarch surgery between January 2002
and December 2012. Calcified aortas and total arch surgeries were excluded. DHCA alone was used for 276 pa-
tients, DHCA with antegrade cerebral perfusion (ACP) was used for 114 patients, and DHCA with retrograde
cerebral perfusion (RCP) was used for 77 patients.
Results: Preoperative characteristics were similar between groups (12.3% in the DHCA group, 12.3% in the
ACP group, and 10.3% in RCP group were reoperations). Patients in the DHCA group had shorter cardiopulmo-
nary bypass times (193 minutes vs 217 minutes; P .005) and total lower body ischemic times (21 minutes vs 30
minutes; P .001) than ACP, but not RCP. Rates of reoperations for bleeding, postoperative stroke, and new renal
failure did not differ between groups. New onset of cerebrovascular events were seen in 5.4% of patients in the
DHCA group versus 6.2% of patients in the ACP group and 6.4% of patients in the RCP group (allP values>.7).
Operative mortality in the DHCA group was 4.7% versus 2.6% in the ACP group and 2.6% in the RCP group
(all P values> .4). Cox proportional hazard modeling showed no survival differences between groups.
Conclusions: Outcomes and survival using DHCA alone were comparable to adjunct cerebral protection
methods in patients undergoing noncomplex hemiarch surgery. DHCA alone is as safe as other adjunct complex
cerebral protection techniques and simplifies operation without additional risk. (J Thorac Cardiovasc Surg
2014;148:2911-7)See related commentary on pages 2917-9.
A
C
DDeep hypothermic circulatory arrest (DHCA) revolution-
ized the surgical treatment for aortic arch disease.1 The
introduction of DHCA dramatically improved the safety
of the operation, although longer durations of circulatory ar-
rest are associated with increased neurologic complications.
Even with DHCA at 18C, there remains a 12% to 25%
cellular metabolic rate compared with normal body temper-
ature.2 The threshold for increased incidence of neurologic
complications has been reported to be at DHCA time of 25
to 40 minutes.3-6 To overcome this limitation, 2 adjunctivee Division of Cardiac Surgery, Brigham and Women’s Hospital, Boston,
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The Journal of Thoracic and Carstrategies have been introduced, namely antegrade cerebral
perfusion (ACP) and retrograde cerebral perfusion (RCP).
These techniques are used in addition to the already
established hypothermic circulatory arrest technique.
Multiple studies have been conducted to identify the safest
cerebral protection strategy, and the answer remains contro-
versial.7-12 No randomized control study has been conducted
to demonstrate the superiority of 1 technique over the other.
Most of the previous studies have compared the outcomes in
the aortic arch, which combines the outcomes of both total
arch replacement and hemiarch replacement.
The advantage of DHCA alone is the simplification of the
procedure by avoiding complex adjunctive cannulation and
perfusion, but it is limited by a shorter acceptable circulatory
arrest time.We defined noncomplex hemiarch surgery as hem-
iarch surgery performed for aneurysmor dissection, but not for
calcified aorta, total arch replacement, or other etiologies. Our
hypothesis was that, in noncomplex hemiarch surgery, which
typically requires shorter circulatory arrest time, DHCA alone
was safe and adjunctive strategies are not needed.
The aim of our study was to assess the mortality and
morbidity, particularly neurologic complications, from
noncomplex hemiarch surgeries using different cerebral
protection strategies and identify whether DHCA alone is
safe compared with adjunctive strategy of ACP and/or RCP.diovascular Surgery c Volume 148, Number 6 2911
Abbreviations and Acronyms
ACP ¼ antegrade cerebral perfusion
CVA ¼ cardiovascular accident
DHCA ¼ deep hypothermic circulatory arrest
ICU ¼ intensive care unit
LOS ¼ length of stay
RCP ¼ retrograde cerebral perfusion
TIA ¼ transient ischemic attack
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Patients and Exclusion Criteria
We identified 467 consecutive patients who underwent noncomplex
hemiarch surgery at our institution between January 2002 and December
2012. We defined noncomplex hemiarch surgery as hemiarch surgery for
aortic aneurysms, acute and chronic dissections without arch replacement,
and excluded operations with calcified aortas. The choice of cerebral pro-
tection strategy was decided by surgeon’s preference. This study was
approved by the Institutional Review Board of Brigham and Women’s
Hospital.
Operative Technique
Cerebral monitoring was performed using right radial arterial pressure,
electroencephalogram, and bispectral index (Phillips, Eindhoven,
Netherlands). In addition, we have used near-infrared spectroscopy cere-
bral monitoring since 2006. All patients underwent median sternotomy.
Arterial cannulation was achieved either directly through the aorta
(69%; 322 out of 468 patients), via right axillary artery (21%; 97 out of
468 patients), or femoral artery (10%; 48 out of 468 patients). One patient
required direct innominate artery cannulation (<1%; 1 out of 468 patients).
For both the right axillary and femoral arterial cannulation, a side-arm graft
technique, with a 6- to 10-mmgraft, was used to avoid distal limb ischemia.
Our cannulation strategy was based on surgeon preference; however, for
most cases our first choice of cannulation for DHCA and/or RCP is direct
aortic cannulation unless it is a reoperation or chronic dissection in which
right axillary or femoral artery is used. When ACP is used, we prefer right
axillary cannulation for cerebral perfusion. For venous drainage, the right
atriumwas cannulated using 3-stage venous cannula. A left ventricular vent
was inserted through the right superior pulmonary vein or left ventricular
apex. Patients were cooled to around 18C until the electroencephalogram
was isoelectric and systemic circulatory arrest was maintained at that point.
Bispectral index and near-infrared spectroscopy were used as an adjunct
and used as a trend rather than specific goal number to guide the degree
of unilateral/bilateral hemispheric ischemia. The patient was placed in
Trendelenburg position and the aorta was opened. We have no standard
strategy of cooling; we cooled to the goal temperature paying attention
to ventricular fibrillation and dilatation. Standard policy of rewarming
was to keep the temperature difference between the body and cardiopulmo-
nary bypass within 10C. Rewarming was completed when the bladder
temperature, not nasopharyngeal temperature, was up to 35.5C.
In the case of DHCA alone, upon completion of the distal anastomosis
and deairing, antegrade systemic perfusion was initiated through the aortic
graft side-arm or direct aortic or other peripheral cannulation. The prox-
imal anastomosis was performed while rewarming.
For ACP, antegrade perfusion from the right axillary artery was initiated
after internal inspection of the aorta and the innominate artery was clamped
with cerebral perfusion established through the right carotid artery. The left
internal carotid artery was also snared/clamped to pressurize the cerebral
circuit. Flow rates were kept around 10 mL/kg/min to maintain the cerebral
arterial pressure around 45 to 60mmHgmonitored by a right radial arterial
line. When axillary artery cannulation was not used, the innominate artery2912 The Journal of Thoracic and Cardiovascular Surwas directly cannulated. On occasion, the left carotid artery was cannu-
lated, if needed. The temperature of cerebral perfusion was at 18C.
Following distal anastomosis, ACP was discontinued and antegrade
systemic perfusion was resumed.
For RCP, the patient was bicavally cannulated. Cerebral perfusion was
initiated through the superior vena cava before circulatory arrest and the su-
perior vena cava was snared. RCPwasmaintained at flow rate of 100 to 300
mL/min to keep the venous perfusion pressure, monitored by a central
venous line, at 25 mm Hg to avoid cerebral edema. The temperature of ce-
rebral perfusion was 18C. Following the distal anastomosis, RCP was
continued to back fill the aortic arch and graft for deairing and debris
removal. RCP was then discontinued and antegrade systemic perfusion
was initiated.
Definition of DHCATime, Cerebral Perfusion Time,
and Total Lower Body Ischemic Time
We defined DHCA time as cerebral circulatory arrest time. Cerebral
perfusion time was total time of ACP and/or RCP time. Therefore total
lower body ischemic time was equal to DHCA time in the DHCA group,
DHCA time þ ACP time (þRCP time) in the ACP group, and DHCA
time þ RCP time in the RCP group.
Data Collection
Patient characteristics, medications, laboratory values, and in-hospital
outcomes of the index surgery were collected at the time of presentation
and extracted from the hospital’s electronic medical records. Data were
coded according to The Society of Thoracic Surgeons National Adult Car-
diac Database version 2.52 definitions unless otherwise noted.
The primary outcomes of interest were operative mortality; frequency of
postoperative complications, mainly cerebrovascular accident (CVA) and
transient ischemic attack (TIA); and long-term survival. CVAwas defined
as any clinical deficit lasting longer than 24 hours and TIAwas defined as
focal neurologic deficit with normal cerebral imaging and resolving in<24
hours. Postoperative complications included CVA or TIA, renal failure,
packed red blood cell transfusion, and reoperation for bleeding. Ventilator
times, intensive care unit (ICU) time, and hospital length of stay (LOS)
were also measured. Mortality data was collected from hospital records,
routine patient follow-up, state Department of Public Health, and query
of the Social Security Death Index.
Statistical Analyses
Evaluation of dichotomous variables was done with Fisher exact test,
and results are presented as percent and number of cases. Continuously
distributed variables were evaluated using Student t test with Levine’s
test for homogeneity of variance; these data are presented as means and
standard deviations. Mann-Whitney U tests were used to evaluate nonnor-
mally distributed continuous variables and are presented as medians and in-
terquartile ranges (IQRs). Risk factors for late mortality were evaluated
using a multivariable Cox proportional hazards model; tested variables
were selected on the basis of known risk factors from the literature, those
that differed significantly between groups, and clinically important variable
expected to affect survival. Interaction terms were examined. All statistical
analyses were performed using SPSS 13.0 (IBM SPSS Inc, Armonk, NY).RESULTS
Study Population
Out of 467 patients who underwent noncomplex hemi-
arch surgery, 276 received DHCA alone (59.1%), 114
received DHCA with ACP (24.4%), and 77 received
DCHA with RCP (16.4%). In the ACP group, 8 out of
114 patients used DHCA with both ACP and RCP. Wegery c December 2014
TABLE 1. Preoperative characteristics of patients undergoing each cerebral protection method
Characteristic
DHCA only DHCAw/ACP DHCAw/RCP P 
(n ¼ 276) (n ¼ 114) (n ¼ 77) 1 v 2 1 v 3 2 v 3
Age (y) 61.1  13.9 61.6  13.3 64.4  13.0 .740 .059 .162
>80 8.0 (22) 8.8 (10) 10.3 (8) .840 .496 .803
Women 32.8 (91) 28.1 (32) 32.1 (25) .401 1.000 .630
Renal failure 2.2 (6) 3.5 (4) 2.6 (2) .487 .690 1.000
Preop creatinine 1.1  0.6 1.0  0.4 1.0  0.4 .654 .860 .526
Diabetes 10.9 (30) 7.9 (9) 7.7 (6) .460 .526 1.000
Hypercholesterolemia 52.2 (144) 50.9 (58) 47.4 (37) .825 .522 .662
Hypertension 63.0 (174) 66.7 (76) 61.5 (47) .562 .895 .539
Cardiogenic shock 1.1 (3) 1.8 (2) 2.6 (2) .632 .304 1.000
Preop CVA 3.6 (10) 7.9 (9) 2.6 (2) .117 1.000 .204
Peripheral vascular disease 37.6 (104) 18.4 (21) 21.8 (17) .001 .010 .584
Family history of CAD 17.5 (48) 21.1 (24) 17.9 (14) .393 .866 .713
NYHA functional class
I 38.0 (105) 33.3 (38) 34.6 (27) .420 .690 .877
II 42.0 (116) 46.5 (53) 38.5 (30) .433 .695 .327
III 16.3 (45) 17.5 (20) 23.1 (18) .767 .178 .358
IV 3.6 (10) 2.6 (3) 3.8 (3) .764 1.000 .687
Ejection fraction (%) 60 (50-65) 60 (55-65) 60 (55-60) .028 .685 .140
Emergency 6.5 (18) 7.9 (9) 9.0 (7) .663 .456 .796
Previous CABG or valve procedure 12.3 (34) 12.3 (14) 10.3 (8) 1.000 .696 .818
Indication for aorta surgery
Aneurysm 88.8 (245) 86.0 (98) 85.9 (66) .494 .434 1.000
Acute dissection 9.4 (26) 10.5 (12) 12.8 (10) .711 .394 .648
Chronic dissection 1.8 (5) 3.5 (4) 1.3 (1) .294 1.000 .650
Values are given as mean  standard deviation,% (n), or median (interquartile range). DHCA, Deep hypothermic circulatory arrest; ACP, antegrade cerebral perfusion; RCP,
retrograde cerebral perfusion; CVA, cerebrovascular accident; CABG, coronary artery bypass graft; CAD, coronary artery disease; NYHA, New York Heart Association.
Kaneko et al Acquired Cardiovascular Disease
A
C
Dincluded these patients in ACP group because the RCP in
these patients was mainly used for deairing and removing
debris. The study follow-up time was 2159 patient years,
with a median observation time of 4.3 years (IQR, 2.2-6.7
years).
Table 1 shows the preoperative characteristics in each
group. Patients in the RCP group tended to be older than
in the DHCA group (64.4 13.0 years vs 61.1 13.9 years,
respectively; P ¼ .059), but similar to patients in the ACP
group (61.6  13.3 years; P>.1). There was a higher inci-
dence of peripheral vascular disease in patients in the
DHCA group (37.6%) compared with patients in the ACP
group (18.4%; P ¼ .001) and RCP group (21.8%;
P ¼ .010). Preoperative stroke was similar across groups
(3.6% DHCA only, 7.9% ACP group, 2.6% RCP group;
all P values> .1). Reoperation rates were 12.3% in the
DHCA group, 12.3% in the ACP group, and 10.3% in
the RCP group (P>.6). All other preoperative characteris-
tics were also similar, including cardiogenic shock, hyper-
tension, diabetes, and renal failure.
Indication for aortic surgery was aneurysm in 88.8% for
the DHCA group, 86% for ACP group, and 85.9% for RCP
group, and were all statistically similar (P > .4). The
remainder surgeries were for acute (9.4% vs 10.5% vs
12.8%) and chronic (1.8% vs 3.5% vs 1.3%) dissection.The Journal of Thoracic and CarEmergency surgery was performed in 6.5% for patients in
the DHCA group, 7.9% for patients in the ACP group,
and 9.0% in patients in the RCP group (P>.4).
Concomitant Procedures
Concomitant procedures and cannulation techniques
performed during the noncomplex hemiarch surgery are
listed in Table 2. Patients in the DHCA group had more
concomitant aortic valve replacement compared with pa-
tients in the ACP group (81.1% vs 71.1%; P ¼ .031)
and in the RCP group (67.7%; P ¼ .013). Also, when
compared with patients in the RCP group, patients in the
DHCA group had a tendency toward fewer concomitant
mitral valve procedures (DHCA 3.6% vs RCP 9.0%;
P ¼ .067) and tricuspid procedure (DHCA 0.8% vs
RCP 3.9%; P ¼ .071). The rate of concomitant coronary
artery bypass graft procedures performed was similar
across all groups (DHCA 21.5% vs ACP 22.8% vs RCP
19.2%; all P values> .5).
Intraoperative Variables
Arterial cannulation in the DHCA-only group was aortic
in 74.3%, femoral in 13%, and axillary in 12.7%; for pa-
tients in the ACP group arterial cannulation was aortic in
44.7%, axillary in 50%, femoral in 4.4%, and innominatediovascular Surgery c Volume 148, Number 6 2913
TABLE 2. Intraoperative data by each cerebral protection method
Data DHCA only (n ¼ 276) DHCAw/ACP (n ¼ 114) DHCAw/RCP (n ¼ 77)
P 
1 v 2 1 v 3 2 v 3
Concomitant procedure
CABG 21.5 (59) 22.8 (26) 19.2 (15) .789 .754 .595
Aortic valve 81.1 (224) 71.1 (81) 67.7 (52) .031 .013 .633
Mitral valve 3.6 (10) 6.1 (7) 9.0 (7) .282 .067 .573
Tricuspid valve 0.8 (2) 1.8 (2) 3.9 (3) .584 .071 .394
Arterial cannulation
Aortic 74.3 (205) 44.7 (51) 84.6 (66)
Femoral 13.0 (36) 4.4 (5) 9.0 (7)
Axillary 12.7 (35) 50.0 (57) 6.4 (5)
Innominate 0 0.9 (1) 0
Lowest temperature (C) 18.0 (17.0-19.7) 18.0 (18.0-19.3) 18.0 (17.8-20) .001 .011 .784
Perfusion time (min) 193 (158-239) 217 (170-272) 201 (158-246) .005 .800 .046
Crossclamp time (min) 127 (94-172) 157 (113-186) 143 (104-192) .002 .073 .482
DHCA time (min) 21 (15-28) 6 (3-11) 4 (1-14) .001 .001 .126
Cerebral perfusion time (min)
Antegrade 24 (20-30)
Retrograde 4 (2-5) 15 (12-20)
Total lower body ischemic time 21 (15-28) 30 (25-40) 22 (16-29) .001 .298 .001
Transfused pRBC units 3 (2-6) 3 (2-4) 2 (2-4) .697 .626 .806
Values are given as% (n) or median (interquartile range). DHCA, Deep hypothermic circulatory arrest; ACP, antegrade cerebral perfusion; RCP, retrograde cerebral perfusion;
CABG, coronary artery bypass graft; pRBC, packed red blood cell.
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Din 0.9%; for patients in the RCP group arterial
cannulation was aortic in 84.6%, femoral in 9%, and axil-
lary in 6.4%.
Other perioperative outcomes are also shown in Table 2.
When compared with patients in the ACP group, patients in
the DHCA group had significantly shorter perfusion time
(DHCA 193 minutes vs ACP 217 minutes; P ¼ .005) and
crossclamp time (DHCA 127 minutes vs ACP 157 minutes;
P¼ .002). The total lower body ischemic time, measured by
the sum of DHCA, ACP, and RCP time, was significantly
longer in patients in the ACP group compared with patients
in the DHCA group (ACP 30minutes vs DHCA 21minutes;
P ¼ .001) and in the RCP group (vs RCP 22 minutes;
P ¼ .001). Transfusion of packed red blood cells were
similar across all groups.TABLE 3. Comparison of postoperative outcomes by cerebral protection
Outcome
DHCA only DHCAw/ACP
(n ¼ 276) (n ¼ 114)
Operative mortality 4.7 (13) 2.6 (3)
Reoperation for bleeding 1.8 (5) 4.4 (5)
New-onset CVA 5.4 (15) 6.2 (7)
Stroke 4.3 (12) 5.3 (6)
TIA 1.1 (3) 0.9 (1)
New-onset renal failure 2.5 (7) 3.5 (4)
Transfused pRBC units 3 (2-7) 3 (3-5)
Vent time (h) 8.2 (5.1-15.6) 7.0 (4.8-14.0)
Intensive care unit stay (h) 47.0 (25-86) 47.0 (26-91)
Length of stay (d) 7 (5-10) 7 (6-10)
Values are given as% (n) or median (interquartile range). DHCA, Deep hypothermic circu
CVA, cerebrovascular accident; TIA, transient ischemic attack; pRBC, packed red blood c
2914 The Journal of Thoracic and Cardiovascular SurPostoperative Outcomes
Postoperative outcomes are listed in Table 3. Operative
mortalities were statistically similar across all groups
(DHCA 4.7%, ACP 2.6%, and RCP 2.6%; all P values
> .4). Overall adverse cerebrovascular outcomes were
similar among groups for permanent stroke (DHCA 4.3%,
ACP 5.3%, and RCP 6.4%; all P values>.5) and transient
ischemic attacks (DHCA 1.1%, ACP 0.9%, and RCP 0%;
all P values>.5). Other complication rates, including reop-
eration for bleeding and renal failure were also similar.
Median ventilation timewas longer in patients in the RCP
group (10.3 hours) compared with patients in the ACP (7.0
hours; P ¼ .015) and DHCA groups (8.2 hours; P ¼ .076).
However median ICU and postoperative LOS did not differ
substantially between groups (Table 3).method
DHCAw/RCP P 
(n ¼ 77) 1 v 2 1 v 3 2 v 3
2.6 (2) .415 .537 1.000
2.6 (2) .164 .652 .703
6.4 (5) .811 .780 1.000
6.4 (5) .791 .546 .756
0.0 (0) .500 1.000 1.000
3.8 (3) .737 .464 1.000
2 (2-6) .580 .796 .911
10.3 (6.3-18.5) .166 .076 .015
44.5 (24-92) .973 .559 .506
7 (5-11) .197 .894 .369
latory arrest; ACP, antegrade cerebral perfusion; RCP, retrograde cerebral perfusion;
ell.
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TABLE 4. Cox regression analysis: Significant predictors of
postoperative survival
Predictor P  HR
95% CI
Lower Upper
Preoperative renal failure .056 3.167 0.970 10.342
Age (y) .001 1.068 1.043 1.092
Total lower body ischemic time (min) .001 1.032 1.015 1.049
Diabetes .003 2.457 1.357 4.464
Nonsignificant variables tested
Lowest system temperature .180
Previous procedure .346
Hypercholesterolemia .445
NYHA functional class .713
Smoker .809
Perfusion method .861
Family history of CAD .878
Gender .912
Overall model performance: 2 log likelihood ¼ 717.446, X2 ¼ 94.665, df ¼ 6,
P<.001. CI, Confidence interval; HR, hazard ratio; NYHA, New York Heart Associ-
ation; CAD, coronary artery disease.
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DLong-Term Outcomes
We used a Cox proportional hazards analysis to evaluate
predictors of long-term survival. Table 4 shows the signifi-
cant contributors in the final model. In order of increasing
significance, preoperative renal failure (hazard ratio
[HR], 3.167; 95% confidence interval [CI], 0.97-10.342;
P ¼ .056), diabetes (HR, 0.407; 95% CI, 0.224-0.737;
P ¼ .003), age in years (HR, 1.068; 95% CI, 1.043-
1.092; P  .001), and total lower body ischemic time
(HR, 1.032; 95% CI, 1.015-1.049; P  .001) were associ-
ated with shorter postoperative survival. Neither lower
body temperature (P ¼ .180) nor perfusion method
(P¼ .861) was significantly predictive of postoperative sur-
vival. Other noncontributory variables tested included reop-
eration, hypercholesterolemia, NewYork Heart Association
functional classification, smoking history, family history of
coronary artery disease, and gender. Figure 1 shows the sur-
vival curves of the 3 perfusion groups.DISCUSSION
The results of our study demonstrated that DHCA alone
without adjunctive strategy had similar operative mortality,
morbidity, and long-term survival compared with adjunc-
tive methods of ACP and/or RCP in patients undergoing
noncomplex hemiarch surgery. Total lower body ischemic
time, perfusion time, and aortic crossclamp time was
shorter in DHCA alone compared with ACP, whereas
neurologic complication rates and lengths of ICU stay and
total LOS were similar across groups. These finding support
that DHCA alone is an adequate cerebral protection strategy
during noncomplex hemiarch surgery.
There has been no consensus about which cerebral pro-
tection strategy is superior for aortic arch surgery. Multiple
retrospective studies have shown contradictory outcomes inThe Journal of Thoracic and Carmortality and neurologic complications.8,10-12 Even in a
study showing a survival benefit with ACP, this benefit
was limited to total aortic arch surgery.9
The Achilles heel of DHCA alone as a cerebral protection
strategy has been that the risks of neurologic dysfunction
increase after a short period. For this reason, advocates of
adjunctive cerebral protection methods have criticized
DHCA alone. Gega and colleagues6 found that DHCA>40
minutes was associated with increased mortality and stroke
rate as high as 13%. Other investigators have claimed that
neurologic risks increase after only 20 to 30minutes of circu-
latory arrest.13,14 In noncomplex hemiarch surgery, systemic
perfusion can be restarted after a quick distal anastomosis.
As shown in our study, it is possible to perform this
procedure in a short time period. Our median DHCA time
was 21 minutes (IQR, 15 to 28 minutes). This technique
simplifies the field1 and avoids the cumbersome adjunctive
cannulation of axillary or innominate artery needed in ACP
with attendant risks. Schachner and colleagues15 reported
technical problems in 14% and a complication rate of 11%
using right axillary cannulation for aortic surgery.15
There are disadvantages to using ACP and RCP. For ACP,
there is no standardization of appropriate flow rates.2 Hy-
perperfusion can lead to cerebral edema whereas hypoper-
fusion can cause cerebral damage. There is also concern
for particulate embolism and vascular injury during cannu-
lation. RCP is becoming less popular given the evidence of
less oxygen reaching the brain and more blood flowing into
the collaterals rather than the brain.16
Neurologic complications are 1 of the most serious
adverse events following cardiac surgery. The stroke rate
in arch surgery has been reported to be 0% to 15%.8-12
Our results are well within this range. One randomized
control study compared the cerebral protection strategies
in aortic arch surgery7 and showed that DHCA alone was
superior in postoperative long-term neurocognitive tests.
However this study had a small number of patients
(n ¼ 10) in each group. Some retrospective studies have
shown increased neurologic dysfunction with DHCA
alone,11,12,17 but most studies included both hemiarch and
total arch surgery. Increasing DHCA time is a risk factor
for stroke18; therefore, noncomplex hemiarch surgery
with shorter DHCA time should be associated with fewer
neurologic events. In our study of hemiarch surgery alone,
the outcomes were similar across all groups.
Similar to other studies, theDHCAgroup in our study also
had shorter cardiopulmonary bypass and aortic crossclamp
times.8,9 There are several possible explanations for this.
First, lower body ischemic time was shorter in the DHCA
group. The lack of an adjunctive method may drive a
surgeon to complete the anastomosis faster. Second,
concomitant procedures such as mitral and tricuspid valve
surgery may have contributed to longer bypass time in the
ACP group. Finally, only 3 surgeons performed this DHCAdiovascular Surgery c Volume 148, Number 6 2915
FIGURE 1. Cox regression analysis for survival after aortic valve replacement by preoperative ejection fraction. DHCA, Deep hypothermic circulatory
arrest.
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performed and may have created bias.
Our Cox proportional hazards analysis showed that preop-
erative renal failure, diabetes, increased age, and longer total
lower body ischemic time were associated with shortened
survival. This emphasizes the importance of performing the
anastomosis quickly to keep the circulatory arrest time short.
Our findings are in line with previous reports identifying
age,18 preoperative renal failure,19 and urgent/emergent
operation20 as risk factors formortality. However in our study
other risk factors thought to be important such as lowest sys-
temic temperature, reoperation, and gender were not signifi-
cant predictors. Most importantly the method of cerebral
protection was not a predictor for survival.
Recently cerebral protection with ACP and moderate hy-
pothermia (22C-28C) has been reported to improve opera-
tive mortality, reduce neurologic complications, and shorten
cardiopulmonary bypass time compared with DHCA.20,21
Also, unilateral ACP allowed 30 to 50 minutes of
circulatory arrest, whereas bilateral ACP allowed 86 to 164
minutes with low neurologic complication rate< 5%.22
We have not applied the moderate hypothermia methods to
our practice, and it is beyond our study to analyze whether
these methods will improve the outcomes in patients in the
ACP group compared with DHCA alone.
Our study is 1 of the largest studies to compare cerebral
protection strategies focusing on noncomplex hemiarch2916 The Journal of Thoracic and Cardiovascular Sursurgeries. We did not find any differences in operative mor-
tality, stroke rate, or postoperative survival. We also identi-
fied multiple risk factors for patients undergoing
noncomplex hemiarch surgery for aortic aneurysm and
acute or chronic aortic dissection. Among the various risks,
cerebral protection strategy was not a risk factor by itself.
These findings confirm the safety of DHCA alone without
adjunctive strategy in patients undergoing this type of
surgery.Limitations
This was a single-institution nonrandomized retrospec-
tive study and is subject to all the limitations inherent in
such a design. Our institution is a tertiary hospital, and
our results may not be generalizable to other patient popu-
lations. The type of cerebral protection used was at the sur-
geon’s discretion, which may be a source of bias. Selection
bias may introduce the possibility that our findings reflect
practitioner differences as well as differences in cerebral
protection methods. Our study contained too few patients
to allow for meaningful subgroup analyses to further quan-
tify and evaluate these issues. Regardless this is one of the
largest studies conducted regarding this subject.CONCLUSIONS
DHCA alone without an adjunctive cerebral protection
strategy is a safe and effective method for noncomplexgery c December 2014
Kaneko et al Acquired Cardiovascular Diseasehemiarch operations. Outcomes, including mortality, neuro-
logic complications, and long-term survival using DHCA
alonewere comparable to adjunct cerebral protectionmethods.References
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C
DBelt and suspenders: Can we keep them in the drawer?Joseph Schmoker, MDIn this issue of the Journal, Kaneko and colleagues1 report
their institutional experiencewith cerebral protection strate-
gies in patients undergoing proximal aortic arch resection
for aneurysms and dissection. This is a large contemporary
series spanning a 10-year period, and at face value the re-
sults show that the adjunctive protection measures of ante-
grade cerebral perfusion (ACP) or retrograde cerebral
perfusion (RCP) offer no added benefit to deep hypothermic
circulatory arrest (DHCA) alone in the prevention of cere-
bral morbidity, such as stroke or transient ischemic attack.
This complements a recently published large series of pa-
tients from another experienced group who also reported
low cerebral morbidity with the use of DHCA alone for
hemiaortic arch replacement.2diovascular Surgery c Volume 148, Number 6 2917
